Technology Detail


The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.
Contact | 
Explore Technologies



G-Protein-Linked Receptor-Transfected Lymphoid Cell as Tools for Drug Discovery and for Cellular Therapeutics


Stanford Reference:

95-006


Abstract


This invention consists of mouse L1/2 pre B cells and human Jurkat cells transfected with serpentine receptors. These cell lines have been shown to be induced by specific ligands to activate lymphoid cell integrins and hence cell adhesion. In many instances, they have been shown to support lymphoid cell chemotaxis as well.

Available cell lines include:

L1/2 mouse pre B cells transfected with:
-- IL8 receptor A
-- IL8 receptor B
-- the human C5a receptor
-- the human formyl peptide receptor
-- CC-CKR-1, the human MIP1a/RANTES receptor

Human Jurkat T cells transfected with:
-- IL8 receptor A

Applications


  • A tool to screen drugs inhibiting the pathway leading from chemoattractant/ agonist to receptor binding to intracellular signaling to integrin activation and cytoskeletal remodeling and hence to adhesion and chemotaxis.

Advantages


  • High throughput screening

Publications


  • Honda, S. et al Butcher, E.C., Journal of Immunology. 152:4026-4035, 1994.

Innovators & Portfolio



Date Released

 8/20/1997 12:00
 

Licensing Contact


Agreements Group
Request Info

79-066 Mouse Anti-Human Hybridomas: 12E7, L243, L17F12, L368
82-008 A Monoclonal Antibody Specific For Mouse Granulocytes - RB6-8C5 and RA3-6B2
82-010 A Monoclonal Antibody Specific for the B-220 Surface Glycoprotein in Mouse (RA3-3A1)

more technologies »

Related Keywords


research tool   LS: research tool: cell line   LS: research tool: antibody   screening